enGene Therapeutics Inc. (ENGN) › Total AssetsenGene Therapeutics Inc. (ENGN) — Total AssetsAnnual figures by period end, from SEC filings.2022-10-31: $23.91M2023-10-31: $86.96M2024-10-31: $311.17M2025-10-31: $221.47M$221.47M2022-10-31Total Assets (USD)2025-10-31Period endedTotal AssetsChange YoYSource filing2025-10-31$221.47M-28.8%2025-12-22Balance as of period end2024-10-31$311.17M+257.8%2025-12-22Balance as of period end2023-10-31$86.96M+263.7%2024-12-19Balance as of period end2022-10-31$23.91M—2024-01-29Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)